Swets M - Search Results

1

Novel avenues in immunotherapies for colorectal cancer.

Pardieck IN, Jawahier PA, Swets M, van de Velde CJ, Kuppen PJ. Pardieck IN, et al. Among authors: swets m. Expert Rev Gastroenterol Hepatol. 2016;10(4):465-80. doi: 10.1586/17474124.2016.1122522. Epub 2015 Dec 17. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26582071 Review.

2

Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer.

Swets M, Seneby L, Boot A, van Wezel T, Gelderblom H, van de Velde CJ, van den Elsen PJ, Kuppen PJ. Swets M, et al. Hum Immunol. 2016 Sep;77(9):764-72. doi: 10.1016/j.humimm.2016.05.023. Epub 2016 May 28. Hum Immunol. 2016. PMID: 27245757

3

The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment.

de Vries NL, Swets M, Vahrmeijer AL, Hokland M, Kuppen PJ. de Vries NL, et al. Among authors: swets m. Int J Mol Sci. 2016 Jun 29;17(7):1030. doi: 10.3390/ijms17071030. Int J Mol Sci. 2016. PMID: 27367680 Free PMC article. Review.

4

Adjuvant chemotherapy for rectal cancer - authors' reply.

Breugom AJ, Swets M, van de Velde CJ. Breugom AJ, et al. Among authors: swets m. Lancet Oncol. 2015 Apr;16(4):e155. doi: 10.1016/S1470-2045(15)70110-5. Lancet Oncol. 2015. PMID: 25846091 No abstract available.

5

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.

Hoekstra E, Das AM, Swets M, Cao W, van der Woude CJ, Bruno MJ, Peppelenbosch MP, Kuppen PJ, Ten Hagen TL, Fuhler GM. Hoekstra E, et al. Among authors: swets m. Oncotarget. 2016 Apr 19;7(16):21922-38. doi: 10.18632/oncotarget.7829. Oncotarget. 2016. PMID: 26942883 Free PMC article.

6

HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases.

Swets M, König MH, Zaalberg A, Dekker-Ensink NG, Gelderblom H, van de Velde CJ, van den Elsen PJ, Kuppen PJ. Swets M, et al. Hum Immunol. 2016 Sep;77(9):773-9. doi: 10.1016/j.humimm.2016.03.001. Epub 2016 Mar 8. Hum Immunol. 2016. PMID: 26968946

7

Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.

Trinh A, Trumpi K, De Sousa E Melo F, Wang X, de Jong JH, Fessler E, Kuppen PJ, Reimers MS, Swets M, Koopman M, Nagtegaal ID, Jansen M, Hooijer GK, Offerhaus GJ, Kranenburg O, Punt CJ, Medema JP, Markowetz F, Vermeulen L. Trinh A, et al. Among authors: swets m. Clin Cancer Res. 2017 Jan 15;23(2):387-398. doi: 10.1158/1078-0432.CCR-16-0680. Epub 2016 Jul 26. Clin Cancer Res. 2017. PMID: 27459899

8

Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer.

Swets M, Zaalberg A, Boot A, van Wezel T, Frouws MA, Bastiaannet E, Gelderblom H, van de Velde CJ, Kuppen PJ. Swets M, et al. Int J Mol Sci. 2016 Dec 27;18(1):36. doi: 10.3390/ijms18010036. Int J Mol Sci. 2016. PMID: 28035987 Free PMC article.

9

Are pathological high-risk features in locally advanced rectal cancer a useful selection tool for adjuvant chemotherapy?

Swets M, Kuppen PJK, Blok EJ, Gelderblom H, van de Velde CJH, Nagtegaal ID. Swets M, et al. Eur J Cancer. 2018 Jan;89:1-8. doi: 10.1016/j.ejca.2017.11.006. Epub 2017 Dec 7. Eur J Cancer. 2018. PMID: 29223019

10

HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic.

Swets M, Wouters A, Krijgsman D, van Vlierberghe RLP, Boot A, van Eendenburg JD, van Wezel T, Gelderblom H, van de Velde CJH, van den Elsen PJ, Kuppen PJK. Swets M, et al. Clin Immunol. 2018 Sep;194:80-86. doi: 10.1016/j.clim.2018.07.005. Epub 2018 Jul 10. Clin Immunol. 2018. PMID: 30006120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page